|Bid||23.43 x 1200|
|Ask||23.44 x 1400|
|Day's range||22.85 - 23.91|
|52-week range||17.99 - 50.77|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||12 May 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||33.27|
Joining me today are Shawn Morris, our chief executive officer; Parth Mehrotra, president and chief operating officer; and David Mountcastle, our chief financial officer. This call is being webcast and can be accessed from the Investor Relations section of priviahealth.com.
Privia Health (PRVA) delivered earnings and revenue surprises of 500% and 5.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Updated financial guidance reflects strong Q1 performance and business momentumPractice Collections +63.3% compared to 1Q’21Implemented Providers +27.3% compared to 1Q’21Value-Based Care Attributed Lives +17.6% compared to 1Q’21 ARLINGTON, Va., May 12, 2022 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31, 2022. Total revenue for the first quarter of 2022 was $313.8 million, compared to total revenue of $213.6 mil